nodes	percent_of_prediction	percent_of_DWPC	metapath
Prednisone—ALB—Erlotinib—pancreatic cancer	0.0792	0.123	CbGbCtD
Prednisone—ALB—Irinotecan—pancreatic cancer	0.0715	0.111	CbGbCtD
Prednisone—ALB—Fluorouracil—pancreatic cancer	0.0686	0.106	CbGbCtD
Prednisone—CYP2C19—Tamoxifen—pancreatic cancer	0.0604	0.0935	CbGbCtD
Prednisone—ABCB1—Tamoxifen—pancreatic cancer	0.0487	0.0754	CbGbCtD
Prednisone—ABCB1—Gemcitabine—pancreatic cancer	0.042	0.065	CbGbCtD
Prednisone—ABCB1—Erlotinib—pancreatic cancer	0.0414	0.0641	CbGbCtD
Prednisone—ABCB1—Irinotecan—pancreatic cancer	0.0374	0.0579	CbGbCtD
Prednisone—CYP3A4—Tamoxifen—pancreatic cancer	0.0292	0.0452	CbGbCtD
Prednisone—ABCB1—Docetaxel—pancreatic cancer	0.0274	0.0425	CbGbCtD
Prednisone—ABCB1—Sunitinib—pancreatic cancer	0.0273	0.0423	CbGbCtD
Prednisone—CYP3A4—Erlotinib—pancreatic cancer	0.0248	0.0384	CbGbCtD
Prednisone—CYP3A4—Irinotecan—pancreatic cancer	0.0224	0.0347	CbGbCtD
Prednisone—ABCB1—Doxorubicin—pancreatic cancer	0.0204	0.0316	CbGbCtD
Prednisone—CYP3A4—Docetaxel—pancreatic cancer	0.0164	0.0254	CbGbCtD
Prednisone—CYP3A4—Sunitinib—pancreatic cancer	0.0163	0.0253	CbGbCtD
Prednisone—CYP3A4—Doxorubicin—pancreatic cancer	0.0122	0.019	CbGbCtD
Prednisone—Insomnia—Gemcitabine—pancreatic cancer	0.00025	0.000726	CcSEcCtD
Prednisone—Dyspepsia—Irinotecan—pancreatic cancer	0.000249	0.000725	CcSEcCtD
Prednisone—Immune system disorder—Docetaxel—pancreatic cancer	0.000249	0.000724	CcSEcCtD
Prednisone—Headache—Erlotinib—pancreatic cancer	0.000249	0.000724	CcSEcCtD
Prednisone—Osteoarthritis—Doxorubicin—pancreatic cancer	0.000249	0.000723	CcSEcCtD
Prednisone—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	0.000249	0.000723	CcSEcCtD
Prednisone—Paraesthesia—Gemcitabine—pancreatic cancer	0.000248	0.00072	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	0.000247	0.000719	CcSEcCtD
Prednisone—Asthenia—Sunitinib—pancreatic cancer	0.000247	0.000717	CcSEcCtD
Prednisone—Dry skin—Epirubicin—pancreatic cancer	0.000246	0.000716	CcSEcCtD
Prednisone—Decreased appetite—Irinotecan—pancreatic cancer	0.000246	0.000716	CcSEcCtD
Prednisone—Arrhythmia—Docetaxel—pancreatic cancer	0.000246	0.000716	CcSEcCtD
Prednisone—Insomnia—Fluorouracil—pancreatic cancer	0.000245	0.000714	CcSEcCtD
Prednisone—Affect lability—Doxorubicin—pancreatic cancer	0.000245	0.000712	CcSEcCtD
Prednisone—Hypokalaemia—Epirubicin—pancreatic cancer	0.000245	0.000711	CcSEcCtD
Prednisone—Fatigue—Irinotecan—pancreatic cancer	0.000244	0.00071	CcSEcCtD
Prednisone—Paraesthesia—Fluorouracil—pancreatic cancer	0.000244	0.000708	CcSEcCtD
Prednisone—Alopecia—Docetaxel—pancreatic cancer	0.000244	0.000708	CcSEcCtD
Prednisone—Pruritus—Sunitinib—pancreatic cancer	0.000243	0.000707	CcSEcCtD
Prednisone—Constipation—Irinotecan—pancreatic cancer	0.000242	0.000704	CcSEcCtD
Prednisone—Mental disorder—Docetaxel—pancreatic cancer	0.000241	0.000702	CcSEcCtD
Prednisone—Face oedema—Doxorubicin—pancreatic cancer	0.00024	0.000698	CcSEcCtD
Prednisone—Erythema—Docetaxel—pancreatic cancer	0.00024	0.000698	CcSEcCtD
Prednisone—Malnutrition—Docetaxel—pancreatic cancer	0.00024	0.000698	CcSEcCtD
Prednisone—Decreased appetite—Gemcitabine—pancreatic cancer	0.00024	0.000697	CcSEcCtD
Prednisone—Dyspepsia—Fluorouracil—pancreatic cancer	0.000239	0.000694	CcSEcCtD
Prednisone—Nausea—Tamoxifen—pancreatic cancer	0.000238	0.000693	CcSEcCtD
Prednisone—Fatigue—Gemcitabine—pancreatic cancer	0.000238	0.000692	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Epirubicin—pancreatic cancer	0.000237	0.000689	CcSEcCtD
Prednisone—Muscular weakness—Epirubicin—pancreatic cancer	0.000237	0.000689	CcSEcCtD
Prednisone—Cardiac arrest—Doxorubicin—pancreatic cancer	0.000236	0.000687	CcSEcCtD
Prednisone—Constipation—Gemcitabine—pancreatic cancer	0.000236	0.000686	CcSEcCtD
Prednisone—Nausea—Erlotinib—pancreatic cancer	0.000236	0.000686	CcSEcCtD
Prednisone—Decreased appetite—Fluorouracil—pancreatic cancer	0.000236	0.000686	CcSEcCtD
Prednisone—Mood swings—Doxorubicin—pancreatic cancer	0.000236	0.000685	CcSEcCtD
Prednisone—Diarrhoea—Sunitinib—pancreatic cancer	0.000235	0.000684	CcSEcCtD
Prednisone—Abdominal distension—Epirubicin—pancreatic cancer	0.000234	0.00068	CcSEcCtD
Prednisone—Feeling abnormal—Irinotecan—pancreatic cancer	0.000233	0.000679	CcSEcCtD
Prednisone—Gastrointestinal pain—Irinotecan—pancreatic cancer	0.000232	0.000674	CcSEcCtD
Prednisone—Dry skin—Doxorubicin—pancreatic cancer	0.000228	0.000663	CcSEcCtD
Prednisone—Pancreatitis—Epirubicin—pancreatic cancer	0.000228	0.000662	CcSEcCtD
Prednisone—Dizziness—Sunitinib—pancreatic cancer	0.000227	0.000661	CcSEcCtD
Prednisone—Feeling abnormal—Gemcitabine—pancreatic cancer	0.000227	0.000661	CcSEcCtD
Prednisone—Hypokalaemia—Doxorubicin—pancreatic cancer	0.000226	0.000658	CcSEcCtD
Prednisone—Abdominal pain—Irinotecan—pancreatic cancer	0.000224	0.000651	CcSEcCtD
Prednisone—Body temperature increased—Irinotecan—pancreatic cancer	0.000224	0.000651	CcSEcCtD
Prednisone—Feeling abnormal—Fluorouracil—pancreatic cancer	0.000224	0.00065	CcSEcCtD
Prednisone—Anaemia—Docetaxel—pancreatic cancer	0.000222	0.000645	CcSEcCtD
Prednisone—Alanine aminotransferase increased—Doxorubicin—pancreatic cancer	0.000219	0.000638	CcSEcCtD
Prednisone—Muscular weakness—Doxorubicin—pancreatic cancer	0.000219	0.000638	CcSEcCtD
Prednisone—Vomiting—Sunitinib—pancreatic cancer	0.000219	0.000636	CcSEcCtD
Prednisone—Body temperature increased—Gemcitabine—pancreatic cancer	0.000218	0.000634	CcSEcCtD
Prednisone—Neutropenia—Epirubicin—pancreatic cancer	0.000217	0.000632	CcSEcCtD
Prednisone—Rash—Sunitinib—pancreatic cancer	0.000217	0.00063	CcSEcCtD
Prednisone—Dermatitis—Sunitinib—pancreatic cancer	0.000217	0.00063	CcSEcCtD
Prednisone—Abdominal distension—Doxorubicin—pancreatic cancer	0.000216	0.000629	CcSEcCtD
Prednisone—Urticaria—Fluorouracil—pancreatic cancer	0.000216	0.000627	CcSEcCtD
Prednisone—Headache—Sunitinib—pancreatic cancer	0.000215	0.000626	CcSEcCtD
Prednisone—Syncope—Docetaxel—pancreatic cancer	0.000215	0.000626	CcSEcCtD
Prednisone—Body temperature increased—Fluorouracil—pancreatic cancer	0.000214	0.000624	CcSEcCtD
Prednisone—Weight increased—Epirubicin—pancreatic cancer	0.000211	0.000615	CcSEcCtD
Prednisone—Loss of consciousness—Docetaxel—pancreatic cancer	0.000211	0.000613	CcSEcCtD
Prednisone—Pancreatitis—Doxorubicin—pancreatic cancer	0.000211	0.000613	CcSEcCtD
Prednisone—Weight decreased—Epirubicin—pancreatic cancer	0.00021	0.000611	CcSEcCtD
Prednisone—Hyperglycaemia—Epirubicin—pancreatic cancer	0.000209	0.000609	CcSEcCtD
Prednisone—Hypersensitivity—Irinotecan—pancreatic cancer	0.000209	0.000607	CcSEcCtD
Prednisone—Convulsion—Docetaxel—pancreatic cancer	0.000208	0.000604	CcSEcCtD
Prednisone—Hypertension—Docetaxel—pancreatic cancer	0.000207	0.000602	CcSEcCtD
Prednisone—Arthralgia—Docetaxel—pancreatic cancer	0.000204	0.000594	CcSEcCtD
Prednisone—Myalgia—Docetaxel—pancreatic cancer	0.000204	0.000594	CcSEcCtD
Prednisone—Nausea—Sunitinib—pancreatic cancer	0.000204	0.000594	CcSEcCtD
Prednisone—Asthenia—Irinotecan—pancreatic cancer	0.000203	0.000591	CcSEcCtD
Prednisone—Neuropathy peripheral—Epirubicin—pancreatic cancer	0.000203	0.00059	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—pancreatic cancer	0.000203	0.00059	CcSEcCtD
Prednisone—Neutropenia—Doxorubicin—pancreatic cancer	0.000201	0.000584	CcSEcCtD
Prednisone—Hypersensitivity—Fluorouracil—pancreatic cancer	0.0002	0.000581	CcSEcCtD
Prednisone—Asthenia—Gemcitabine—pancreatic cancer	0.000198	0.000576	CcSEcCtD
Prednisone—Anaphylactic shock—Docetaxel—pancreatic cancer	0.000196	0.000569	CcSEcCtD
Prednisone—Oedema—Docetaxel—pancreatic cancer	0.000196	0.000569	CcSEcCtD
Prednisone—Weight increased—Doxorubicin—pancreatic cancer	0.000196	0.000569	CcSEcCtD
Prednisone—Pruritus—Gemcitabine—pancreatic cancer	0.000195	0.000568	CcSEcCtD
Prednisone—Infection—Docetaxel—pancreatic cancer	0.000195	0.000566	CcSEcCtD
Prednisone—Weight decreased—Doxorubicin—pancreatic cancer	0.000194	0.000565	CcSEcCtD
Prednisone—Hyperglycaemia—Doxorubicin—pancreatic cancer	0.000194	0.000564	CcSEcCtD
Prednisone—Diarrhoea—Irinotecan—pancreatic cancer	0.000194	0.000564	CcSEcCtD
Prednisone—Shock—Docetaxel—pancreatic cancer	0.000193	0.00056	CcSEcCtD
Prednisone—Nervous system disorder—Docetaxel—pancreatic cancer	0.000192	0.000558	CcSEcCtD
Prednisone—Pruritus—Fluorouracil—pancreatic cancer	0.000192	0.000558	CcSEcCtD
Prednisone—Tachycardia—Docetaxel—pancreatic cancer	0.000191	0.000556	CcSEcCtD
Prednisone—Skin disorder—Docetaxel—pancreatic cancer	0.00019	0.000553	CcSEcCtD
Prednisone—Bradycardia—Epirubicin—pancreatic cancer	0.000189	0.00055	CcSEcCtD
Prednisone—Diarrhoea—Gemcitabine—pancreatic cancer	0.000189	0.000549	CcSEcCtD
Prednisone—Neuropathy peripheral—Doxorubicin—pancreatic cancer	0.000188	0.000546	CcSEcCtD
Prednisone—Dizziness—Irinotecan—pancreatic cancer	0.000187	0.000545	CcSEcCtD
Prednisone—Haemoglobin—Epirubicin—pancreatic cancer	0.000187	0.000543	CcSEcCtD
Prednisone—Anorexia—Docetaxel—pancreatic cancer	0.000187	0.000543	CcSEcCtD
Prednisone—Haemorrhage—Epirubicin—pancreatic cancer	0.000186	0.000541	CcSEcCtD
Prednisone—Diarrhoea—Fluorouracil—pancreatic cancer	0.000186	0.00054	CcSEcCtD
Prednisone—Connective tissue disorder—Epirubicin—pancreatic cancer	0.000183	0.000531	CcSEcCtD
Prednisone—Vomiting—Irinotecan—pancreatic cancer	0.00018	0.000524	CcSEcCtD
Prednisone—Dizziness—Fluorouracil—pancreatic cancer	0.000179	0.000522	CcSEcCtD
Prednisone—Rash—Irinotecan—pancreatic cancer	0.000179	0.000519	CcSEcCtD
Prednisone—Dermatitis—Irinotecan—pancreatic cancer	0.000178	0.000519	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	0.000178	0.000519	CcSEcCtD
Prednisone—Headache—Irinotecan—pancreatic cancer	0.000177	0.000516	CcSEcCtD
Prednisone—Insomnia—Docetaxel—pancreatic cancer	0.000177	0.000515	CcSEcCtD
Prednisone—Paraesthesia—Docetaxel—pancreatic cancer	0.000176	0.000511	CcSEcCtD
Prednisone—Vomiting—Gemcitabine—pancreatic cancer	0.000175	0.00051	CcSEcCtD
Prednisone—Bradycardia—Doxorubicin—pancreatic cancer	0.000175	0.000509	CcSEcCtD
Prednisone—Rash—Gemcitabine—pancreatic cancer	0.000174	0.000506	CcSEcCtD
Prednisone—Dermatitis—Gemcitabine—pancreatic cancer	0.000174	0.000505	CcSEcCtD
Prednisone—Eye disorder—Epirubicin—pancreatic cancer	0.000174	0.000505	CcSEcCtD
Prednisone—Haemoglobin—Doxorubicin—pancreatic cancer	0.000173	0.000503	CcSEcCtD
Prednisone—Headache—Gemcitabine—pancreatic cancer	0.000173	0.000503	CcSEcCtD
Prednisone—Flushing—Epirubicin—pancreatic cancer	0.000173	0.000502	CcSEcCtD
Prednisone—Vomiting—Fluorouracil—pancreatic cancer	0.000172	0.000502	CcSEcCtD
Prednisone—Dyspepsia—Docetaxel—pancreatic cancer	0.000172	0.000501	CcSEcCtD
Prednisone—Haemorrhage—Doxorubicin—pancreatic cancer	0.000172	0.0005	CcSEcCtD
Prednisone—Rash—Fluorouracil—pancreatic cancer	0.000171	0.000497	CcSEcCtD
Prednisone—Dermatitis—Fluorouracil—pancreatic cancer	0.000171	0.000497	CcSEcCtD
Prednisone—Decreased appetite—Docetaxel—pancreatic cancer	0.00017	0.000495	CcSEcCtD
Prednisone—Headache—Fluorouracil—pancreatic cancer	0.00017	0.000494	CcSEcCtD
Prednisone—Connective tissue disorder—Doxorubicin—pancreatic cancer	0.000169	0.000492	CcSEcCtD
Prednisone—Fatigue—Docetaxel—pancreatic cancer	0.000169	0.000491	CcSEcCtD
Prednisone—Angiopathy—Epirubicin—pancreatic cancer	0.000169	0.00049	CcSEcCtD
Prednisone—Nausea—Irinotecan—pancreatic cancer	0.000168	0.000489	CcSEcCtD
Prednisone—Immune system disorder—Epirubicin—pancreatic cancer	0.000168	0.000488	CcSEcCtD
Prednisone—Constipation—Docetaxel—pancreatic cancer	0.000167	0.000487	CcSEcCtD
Prednisone—Arrhythmia—Epirubicin—pancreatic cancer	0.000166	0.000483	CcSEcCtD
Prednisone—Alopecia—Epirubicin—pancreatic cancer	0.000164	0.000478	CcSEcCtD
Prednisone—Nausea—Gemcitabine—pancreatic cancer	0.000164	0.000477	CcSEcCtD
Prednisone—Mental disorder—Epirubicin—pancreatic cancer	0.000163	0.000474	CcSEcCtD
Prednisone—Erythema—Epirubicin—pancreatic cancer	0.000162	0.000471	CcSEcCtD
Prednisone—Malnutrition—Epirubicin—pancreatic cancer	0.000162	0.000471	CcSEcCtD
Prednisone—Feeling abnormal—Docetaxel—pancreatic cancer	0.000161	0.000469	CcSEcCtD
Prednisone—Nausea—Fluorouracil—pancreatic cancer	0.000161	0.000469	CcSEcCtD
Prednisone—Eye disorder—Doxorubicin—pancreatic cancer	0.000161	0.000467	CcSEcCtD
Prednisone—Gastrointestinal pain—Docetaxel—pancreatic cancer	0.00016	0.000466	CcSEcCtD
Prednisone—Flushing—Doxorubicin—pancreatic cancer	0.00016	0.000464	CcSEcCtD
Prednisone—Angiopathy—Doxorubicin—pancreatic cancer	0.000156	0.000454	CcSEcCtD
Prednisone—Immune system disorder—Doxorubicin—pancreatic cancer	0.000155	0.000452	CcSEcCtD
Prednisone—Body temperature increased—Docetaxel—pancreatic cancer	0.000155	0.00045	CcSEcCtD
Prednisone—Abdominal pain—Docetaxel—pancreatic cancer	0.000155	0.00045	CcSEcCtD
Prednisone—Arrhythmia—Doxorubicin—pancreatic cancer	0.000154	0.000447	CcSEcCtD
Prednisone—Vision blurred—Epirubicin—pancreatic cancer	0.000153	0.000443	CcSEcCtD
Prednisone—Alopecia—Doxorubicin—pancreatic cancer	0.000152	0.000442	CcSEcCtD
Prednisone—Mental disorder—Doxorubicin—pancreatic cancer	0.000151	0.000438	CcSEcCtD
Prednisone—Ill-defined disorder—Epirubicin—pancreatic cancer	0.00015	0.000437	CcSEcCtD
Prednisone—Erythema—Doxorubicin—pancreatic cancer	0.00015	0.000435	CcSEcCtD
Prednisone—Malnutrition—Doxorubicin—pancreatic cancer	0.00015	0.000435	CcSEcCtD
Prednisone—Anaemia—Epirubicin—pancreatic cancer	0.00015	0.000435	CcSEcCtD
Prednisone—Agitation—Epirubicin—pancreatic cancer	0.000149	0.000432	CcSEcCtD
Prednisone—Malaise—Epirubicin—pancreatic cancer	0.000146	0.000424	CcSEcCtD
Prednisone—Vertigo—Epirubicin—pancreatic cancer	0.000145	0.000423	CcSEcCtD
Prednisone—Syncope—Epirubicin—pancreatic cancer	0.000145	0.000422	CcSEcCtD
Prednisone—Hypersensitivity—Docetaxel—pancreatic cancer	0.000144	0.00042	CcSEcCtD
Prednisone—Loss of consciousness—Epirubicin—pancreatic cancer	0.000142	0.000414	CcSEcCtD
Prednisone—Vision blurred—Doxorubicin—pancreatic cancer	0.000141	0.00041	CcSEcCtD
Prednisone—Asthenia—Docetaxel—pancreatic cancer	0.00014	0.000409	CcSEcCtD
Prednisone—Convulsion—Epirubicin—pancreatic cancer	0.00014	0.000408	CcSEcCtD
Prednisone—Hypertension—Epirubicin—pancreatic cancer	0.00014	0.000406	CcSEcCtD
Prednisone—Ill-defined disorder—Doxorubicin—pancreatic cancer	0.000139	0.000404	CcSEcCtD
Prednisone—Pruritus—Docetaxel—pancreatic cancer	0.000139	0.000403	CcSEcCtD
Prednisone—Anaemia—Doxorubicin—pancreatic cancer	0.000138	0.000402	CcSEcCtD
Prednisone—Myalgia—Epirubicin—pancreatic cancer	0.000138	0.000401	CcSEcCtD
Prednisone—Arthralgia—Epirubicin—pancreatic cancer	0.000138	0.000401	CcSEcCtD
Prednisone—Agitation—Doxorubicin—pancreatic cancer	0.000138	0.0004	CcSEcCtD
Prednisone—Anxiety—Epirubicin—pancreatic cancer	0.000137	0.000399	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—pancreatic cancer	0.000137	0.000398	CcSEcCtD
Prednisone—Discomfort—Epirubicin—pancreatic cancer	0.000136	0.000396	CcSEcCtD
Prednisone—Malaise—Doxorubicin—pancreatic cancer	0.000135	0.000393	CcSEcCtD
Prednisone—Vertigo—Doxorubicin—pancreatic cancer	0.000135	0.000391	CcSEcCtD
Prednisone—Syncope—Doxorubicin—pancreatic cancer	0.000134	0.00039	CcSEcCtD
Prednisone—Diarrhoea—Docetaxel—pancreatic cancer	0.000134	0.00039	CcSEcCtD
Prednisone—Oedema—Epirubicin—pancreatic cancer	0.000132	0.000384	CcSEcCtD
Prednisone—Anaphylactic shock—Epirubicin—pancreatic cancer	0.000132	0.000384	CcSEcCtD
Prednisone—Loss of consciousness—Doxorubicin—pancreatic cancer	0.000132	0.000383	CcSEcCtD
Prednisone—Infection—Epirubicin—pancreatic cancer	0.000131	0.000382	CcSEcCtD
Prednisone—Shock—Epirubicin—pancreatic cancer	0.00013	0.000378	CcSEcCtD
Prednisone—Convulsion—Doxorubicin—pancreatic cancer	0.00013	0.000377	CcSEcCtD
Prednisone—Nervous system disorder—Epirubicin—pancreatic cancer	0.00013	0.000377	CcSEcCtD
Prednisone—Dizziness—Docetaxel—pancreatic cancer	0.000129	0.000377	CcSEcCtD
Prednisone—Hypertension—Doxorubicin—pancreatic cancer	0.000129	0.000376	CcSEcCtD
Prednisone—Tachycardia—Epirubicin—pancreatic cancer	0.000129	0.000375	CcSEcCtD
Prednisone—Skin disorder—Epirubicin—pancreatic cancer	0.000128	0.000373	CcSEcCtD
Prednisone—Hyperhidrosis—Epirubicin—pancreatic cancer	0.000128	0.000371	CcSEcCtD
Prednisone—Myalgia—Doxorubicin—pancreatic cancer	0.000127	0.000371	CcSEcCtD
Prednisone—Arthralgia—Doxorubicin—pancreatic cancer	0.000127	0.000371	CcSEcCtD
Prednisone—Anxiety—Doxorubicin—pancreatic cancer	0.000127	0.000369	CcSEcCtD
Prednisone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—pancreatic cancer	0.000127	0.000368	CcSEcCtD
Prednisone—Discomfort—Doxorubicin—pancreatic cancer	0.000126	0.000366	CcSEcCtD
Prednisone—Anorexia—Epirubicin—pancreatic cancer	0.000126	0.000366	CcSEcCtD
Prednisone—Vomiting—Docetaxel—pancreatic cancer	0.000124	0.000362	CcSEcCtD
Prednisone—Rash—Docetaxel—pancreatic cancer	0.000123	0.000359	CcSEcCtD
Prednisone—Dermatitis—Docetaxel—pancreatic cancer	0.000123	0.000359	CcSEcCtD
Prednisone—Headache—Docetaxel—pancreatic cancer	0.000123	0.000357	CcSEcCtD
Prednisone—Oedema—Doxorubicin—pancreatic cancer	0.000122	0.000355	CcSEcCtD
Prednisone—Anaphylactic shock—Doxorubicin—pancreatic cancer	0.000122	0.000355	CcSEcCtD
Prednisone—Infection—Doxorubicin—pancreatic cancer	0.000121	0.000353	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	0.00012	0.00035	CcSEcCtD
Prednisone—Shock—Doxorubicin—pancreatic cancer	0.00012	0.00035	CcSEcCtD
Prednisone—Nervous system disorder—Doxorubicin—pancreatic cancer	0.00012	0.000348	CcSEcCtD
Prednisone—Insomnia—Epirubicin—pancreatic cancer	0.000119	0.000347	CcSEcCtD
Prednisone—Tachycardia—Doxorubicin—pancreatic cancer	0.000119	0.000347	CcSEcCtD
Prednisone—Skin disorder—Doxorubicin—pancreatic cancer	0.000119	0.000345	CcSEcCtD
Prednisone—Paraesthesia—Epirubicin—pancreatic cancer	0.000119	0.000345	CcSEcCtD
Prednisone—Hyperhidrosis—Doxorubicin—pancreatic cancer	0.000118	0.000344	CcSEcCtD
Prednisone—Anorexia—Doxorubicin—pancreatic cancer	0.000116	0.000339	CcSEcCtD
Prednisone—Nausea—Docetaxel—pancreatic cancer	0.000116	0.000338	CcSEcCtD
Prednisone—Dyspepsia—Epirubicin—pancreatic cancer	0.000116	0.000338	CcSEcCtD
Prednisone—Decreased appetite—Epirubicin—pancreatic cancer	0.000115	0.000334	CcSEcCtD
Prednisone—Fatigue—Epirubicin—pancreatic cancer	0.000114	0.000331	CcSEcCtD
Prednisone—Constipation—Epirubicin—pancreatic cancer	0.000113	0.000328	CcSEcCtD
Prednisone—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	0.000111	0.000324	CcSEcCtD
Prednisone—Insomnia—Doxorubicin—pancreatic cancer	0.000111	0.000321	CcSEcCtD
Prednisone—Paraesthesia—Doxorubicin—pancreatic cancer	0.00011	0.000319	CcSEcCtD
Prednisone—Feeling abnormal—Epirubicin—pancreatic cancer	0.000109	0.000316	CcSEcCtD
Prednisone—Gastrointestinal pain—Epirubicin—pancreatic cancer	0.000108	0.000314	CcSEcCtD
Prednisone—Dyspepsia—Doxorubicin—pancreatic cancer	0.000108	0.000313	CcSEcCtD
Prednisone—Decreased appetite—Doxorubicin—pancreatic cancer	0.000106	0.000309	CcSEcCtD
Prednisone—Fatigue—Doxorubicin—pancreatic cancer	0.000105	0.000306	CcSEcCtD
Prednisone—Urticaria—Epirubicin—pancreatic cancer	0.000105	0.000305	CcSEcCtD
Prednisone—Constipation—Doxorubicin—pancreatic cancer	0.000104	0.000304	CcSEcCtD
Prednisone—Abdominal pain—Epirubicin—pancreatic cancer	0.000104	0.000304	CcSEcCtD
Prednisone—Body temperature increased—Epirubicin—pancreatic cancer	0.000104	0.000304	CcSEcCtD
Prednisone—Feeling abnormal—Doxorubicin—pancreatic cancer	0.000101	0.000293	CcSEcCtD
Prednisone—Gastrointestinal pain—Doxorubicin—pancreatic cancer	9.99e-05	0.000291	CcSEcCtD
Prednisone—Hypersensitivity—Epirubicin—pancreatic cancer	9.73e-05	0.000283	CcSEcCtD
Prednisone—Urticaria—Doxorubicin—pancreatic cancer	9.71e-05	0.000282	CcSEcCtD
Prednisone—Abdominal pain—Doxorubicin—pancreatic cancer	9.66e-05	0.000281	CcSEcCtD
Prednisone—Body temperature increased—Doxorubicin—pancreatic cancer	9.66e-05	0.000281	CcSEcCtD
Prednisone—Asthenia—Epirubicin—pancreatic cancer	9.48e-05	0.000276	CcSEcCtD
Prednisone—Pruritus—Epirubicin—pancreatic cancer	9.34e-05	0.000272	CcSEcCtD
Prednisone—Diarrhoea—Epirubicin—pancreatic cancer	9.04e-05	0.000263	CcSEcCtD
Prednisone—Hypersensitivity—Doxorubicin—pancreatic cancer	9e-05	0.000262	CcSEcCtD
Prednisone—Asthenia—Doxorubicin—pancreatic cancer	8.77e-05	0.000255	CcSEcCtD
Prednisone—Dizziness—Epirubicin—pancreatic cancer	8.73e-05	0.000254	CcSEcCtD
Prednisone—Pruritus—Doxorubicin—pancreatic cancer	8.65e-05	0.000251	CcSEcCtD
Prednisone—Vomiting—Epirubicin—pancreatic cancer	8.4e-05	0.000244	CcSEcCtD
Prednisone—Diarrhoea—Doxorubicin—pancreatic cancer	8.36e-05	0.000243	CcSEcCtD
Prednisone—Rash—Epirubicin—pancreatic cancer	8.33e-05	0.000242	CcSEcCtD
Prednisone—Dermatitis—Epirubicin—pancreatic cancer	8.32e-05	0.000242	CcSEcCtD
Prednisone—Headache—Epirubicin—pancreatic cancer	8.27e-05	0.000241	CcSEcCtD
Prednisone—Dizziness—Doxorubicin—pancreatic cancer	8.08e-05	0.000235	CcSEcCtD
Prednisone—Nausea—Epirubicin—pancreatic cancer	7.84e-05	0.000228	CcSEcCtD
Prednisone—Vomiting—Doxorubicin—pancreatic cancer	7.77e-05	0.000226	CcSEcCtD
Prednisone—Rash—Doxorubicin—pancreatic cancer	7.7e-05	0.000224	CcSEcCtD
Prednisone—Dermatitis—Doxorubicin—pancreatic cancer	7.7e-05	0.000224	CcSEcCtD
Prednisone—Headache—Doxorubicin—pancreatic cancer	7.66e-05	0.000223	CcSEcCtD
Prednisone—Nausea—Doxorubicin—pancreatic cancer	7.26e-05	0.000211	CcSEcCtD
Prednisone—HSD11B1—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	3.26e-05	0.0031	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—HIF1A—pancreatic cancer	3.24e-05	0.00307	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—PPARG—pancreatic cancer	3.18e-05	0.00302	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	3.17e-05	0.00301	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CG—pancreatic cancer	3.11e-05	0.00295	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	3.11e-05	0.00295	CbGpPWpGaD
Prednisone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	3.08e-05	0.00293	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—RB1—pancreatic cancer	3.05e-05	0.00289	CbGpPWpGaD
Prednisone—NR3C1—Endoderm Differentiation—TGFB1—pancreatic cancer	3.04e-05	0.00289	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PPARG—pancreatic cancer	3e-05	0.00285	CbGpPWpGaD
Prednisone—NR3C1—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	3e-05	0.00284	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—MYC—pancreatic cancer	2.98e-05	0.00283	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TGFB1—pancreatic cancer	2.97e-05	0.00282	CbGpPWpGaD
Prednisone—CYP2C19—Arachidonic acid metabolism—PTGS2—pancreatic cancer	2.96e-05	0.00281	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—EGF—pancreatic cancer	2.95e-05	0.0028	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	2.84e-05	0.0027	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—EGF—pancreatic cancer	2.81e-05	0.00267	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	2.81e-05	0.00266	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—CHD3—pancreatic cancer	2.75e-05	0.00261	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MEN1—pancreatic cancer	2.75e-05	0.00261	CbGpPWpGaD
Prednisone—SLCO1A2—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	2.74e-05	0.0026	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CD—pancreatic cancer	2.73e-05	0.00259	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—pancreatic cancer	2.65e-05	0.00252	CbGpPWpGaD
Prednisone—ALB—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	2.64e-05	0.0025	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH4—pancreatic cancer	2.61e-05	0.00248	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	2.45e-05	0.00233	CbGpPWpGaD
Prednisone—NR3C1—AP-1 transcription factor network—TP53—pancreatic cancer	2.45e-05	0.00232	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	2.41e-05	0.00229	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CB—pancreatic cancer	2.38e-05	0.00226	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTGS2—pancreatic cancer	2.36e-05	0.00224	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NR5A2—pancreatic cancer	2.31e-05	0.00219	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PRSS1—pancreatic cancer	2.25e-05	0.00214	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—CTNNB1—pancreatic cancer	2.24e-05	0.00213	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH3—pancreatic cancer	2.22e-05	0.00211	CbGpPWpGaD
Prednisone—ALB—Vitamin B12 Metabolism—TNF—pancreatic cancer	2.19e-05	0.00208	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	2.16e-05	0.00205	CbGpPWpGaD
Prednisone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—pancreatic cancer	2.13e-05	0.00202	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA5—pancreatic cancer	2.12e-05	0.00201	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CXCL8—pancreatic cancer	2.1e-05	0.00199	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—PTGS2—pancreatic cancer	2.1e-05	0.00199	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	2.06e-05	0.00196	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PTEN—pancreatic cancer	2.06e-05	0.00195	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CASP3—pancreatic cancer	2.01e-05	0.00191	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PPP2R5B—pancreatic cancer	2e-05	0.0019	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—STAT3—pancreatic cancer	1.95e-05	0.00186	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—ARG2—pancreatic cancer	1.95e-05	0.00185	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CXCL8—pancreatic cancer	1.94e-05	0.00185	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—CTNNB1—pancreatic cancer	1.94e-05	0.00184	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	1.87e-05	0.00177	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—CASP3—pancreatic cancer	1.86e-05	0.00177	CbGpPWpGaD
Prednisone—NR3C1—Regulation of nuclear SMAD2/3 signaling—AKT1—pancreatic cancer	1.84e-05	0.00175	CbGpPWpGaD
Prednisone—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—pancreatic cancer	1.84e-05	0.00174	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—pancreatic cancer	1.82e-05	0.00173	CbGpPWpGaD
Prednisone—NR3C1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	1.82e-05	0.00173	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TGFB1—pancreatic cancer	1.81e-05	0.00172	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	1.81e-05	0.00172	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—VEGFA—pancreatic cancer	1.78e-05	0.00169	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TNF—pancreatic cancer	1.78e-05	0.00169	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	1.78e-05	0.00169	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TYMP—pancreatic cancer	1.71e-05	0.00162	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—VEGFA—pancreatic cancer	1.71e-05	0.00162	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—pancreatic cancer	1.7e-05	0.00161	CbGpPWpGaD
Prednisone—NR3C1—Adipogenesis—TNF—pancreatic cancer	1.69e-05	0.00161	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—SMAD4—pancreatic cancer	1.67e-05	0.00159	CbGpPWpGaD
Prednisone—ALB—Platelet degranulation—TGFB1—pancreatic cancer	1.64e-05	0.00155	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—VEGFA—pancreatic cancer	1.58e-05	0.0015	CbGpPWpGaD
Prednisone—ALB—Folate Metabolism—TP53—pancreatic cancer	1.57e-05	0.00149	CbGpPWpGaD
Prednisone—ALB—Response to elevated platelet cytosolic Ca2+—TGFB1—pancreatic cancer	1.56e-05	0.00148	CbGpPWpGaD
Prednisone—NR3C1—SIDS Susceptibility Pathways—TNF—pancreatic cancer	1.46e-05	0.00139	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—PIK3CA—pancreatic cancer	1.45e-05	0.00138	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TGFB1—pancreatic cancer	1.45e-05	0.00138	CbGpPWpGaD
Prednisone—ALB—Selenium Micronutrient Network—TNF—pancreatic cancer	1.42e-05	0.00135	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	1.41e-05	0.00134	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GLP1R—pancreatic cancer	1.38e-05	0.00131	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—DPYD—pancreatic cancer	1.35e-05	0.00129	CbGpPWpGaD
Prednisone—ABCB1—Allograft Rejection—TNF—pancreatic cancer	1.35e-05	0.00129	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	1.35e-05	0.00128	CbGpPWpGaD
Prednisone—ALB—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.34e-05	0.00127	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MEN1—pancreatic cancer	1.33e-05	0.00126	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CG—pancreatic cancer	1.32e-05	0.00126	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—EGF—pancreatic cancer	1.31e-05	0.00124	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	1.29e-05	0.00122	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—SLC2A2—pancreatic cancer	1.28e-05	0.00122	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	1.27e-05	0.00121	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH4—pancreatic cancer	1.26e-05	0.00119	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—NOTCH1—pancreatic cancer	1.23e-05	0.00117	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	1.23e-05	0.00116	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HSPA1B—pancreatic cancer	1.2e-05	0.00114	CbGpPWpGaD
Prednisone—ALB—Hemostasis—CD44—pancreatic cancer	1.2e-05	0.00114	CbGpPWpGaD
Prednisone—HSD11B1—Metabolism—AKT1—pancreatic cancer	1.19e-05	0.00113	CbGpPWpGaD
Prednisone—ABCB1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	1.17e-05	0.00111	CbGpPWpGaD
Prednisone—ABCB1—HIF-1-alpha transcription factor network—AKT1—pancreatic cancer	1.16e-05	0.0011	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CD—pancreatic cancer	1.16e-05	0.0011	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—PPARG—pancreatic cancer	1.16e-05	0.0011	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA1—pancreatic cancer	1.16e-05	0.0011	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	1.12e-05	0.00106	CbGpPWpGaD
Prednisone—ALB—Metabolism—PRSS1—pancreatic cancer	1.1e-05	0.00104	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—EZH2—pancreatic cancer	1.09e-05	0.00104	CbGpPWpGaD
Prednisone—ALB—Hemostasis—IFNA2—pancreatic cancer	1.08e-05	0.00103	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH3—pancreatic cancer	1.07e-05	0.00101	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CB—pancreatic cancer	1.01e-05	0.000963	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—HSPA1A—pancreatic cancer	1.01e-05	0.000961	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—CD44—pancreatic cancer	9.95e-06	0.000944	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	9.89e-06	0.000939	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PRSS1—pancreatic cancer	9.88e-06	0.000938	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	9.74e-06	0.000925	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	9.65e-06	0.000916	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PRSS1—pancreatic cancer	9.64e-06	0.000915	CbGpPWpGaD
Prednisone—ALB—Metabolism—ARG2—pancreatic cancer	9.54e-06	0.000906	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—GCG—pancreatic cancer	9.54e-06	0.000905	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	9.18e-06	0.000872	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—STK11—pancreatic cancer	8.97e-06	0.000851	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	8.94e-06	0.000849	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	8.85e-06	0.00084	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	8.63e-06	0.000819	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—ARG2—pancreatic cancer	8.56e-06	0.000813	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	8.42e-06	0.000799	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—ARG2—pancreatic cancer	8.36e-06	0.000794	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMP—pancreatic cancer	8.34e-06	0.000792	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—SRC—pancreatic cancer	8.13e-06	0.000772	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—SMAD4—pancreatic cancer	8.05e-06	0.000764	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	8e-06	0.00076	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—VEGFA—pancreatic cancer	7.91e-06	0.000751	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	7.79e-06	0.00074	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—TYMS—pancreatic cancer	7.71e-06	0.000732	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PLAU—pancreatic cancer	7.67e-06	0.000728	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMP—pancreatic cancer	7.49e-06	0.000711	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMP—pancreatic cancer	7.31e-06	0.000694	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—TGFB1—pancreatic cancer	7.26e-06	0.00069	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	7.17e-06	0.000681	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	7.15e-06	0.000679	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	7.01e-06	0.000666	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.88e-06	0.000653	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CG—pancreatic cancer	6.82e-06	0.000648	CbGpPWpGaD
Prednisone—ALB—Hemostasis—EGF—pancreatic cancer	6.74e-06	0.00064	CbGpPWpGaD
Prednisone—ALB—Metabolism—GLP1R—pancreatic cancer	6.72e-06	0.000638	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	6.68e-06	0.000634	CbGpPWpGaD
Prednisone—NR3C1—Generic Transcription Pathway—MYC—pancreatic cancer	6.63e-06	0.000629	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	6.63e-06	0.000629	CbGpPWpGaD
Prednisone—ALB—Metabolism—DPYD—pancreatic cancer	6.61e-06	0.000628	CbGpPWpGaD
Prednisone—ALB—Metabolism—SLC2A2—pancreatic cancer	6.28e-06	0.000596	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—APOE—pancreatic cancer	6.27e-06	0.000596	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	6.21e-06	0.00059	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—PIK3CA—pancreatic cancer	6.18e-06	0.000587	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—APOE—pancreatic cancer	6.18e-06	0.000587	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	6.09e-06	0.000578	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GLP1R—pancreatic cancer	6.03e-06	0.000573	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CD—pancreatic cancer	6e-06	0.000569	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.99e-06	0.000569	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PRSS1—pancreatic cancer	5.94e-06	0.000564	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	5.94e-06	0.000564	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—DPYD—pancreatic cancer	5.94e-06	0.000564	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—NOTCH1—pancreatic cancer	5.93e-06	0.000563	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GLP1R—pancreatic cancer	5.89e-06	0.000559	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	5.89e-06	0.000559	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—DPYD—pancreatic cancer	5.79e-06	0.00055	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CG—pancreatic cancer	5.66e-06	0.000537	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—SLC2A2—pancreatic cancer	5.63e-06	0.000535	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—PPARG—pancreatic cancer	5.6e-06	0.000532	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—pancreatic cancer	5.57e-06	0.000529	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—SLC2A2—pancreatic cancer	5.5e-06	0.000522	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PPARG—pancreatic cancer	5.46e-06	0.000519	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	5.46e-06	0.000518	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—pancreatic cancer	5.38e-06	0.000511	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CB—pancreatic cancer	5.23e-06	0.000496	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—ARG2—pancreatic cancer	5.15e-06	0.000489	CbGpPWpGaD
Prednisone—ALB—Platelet activation, signaling and aggregation—AKT1—pancreatic cancer	5.05e-06	0.000479	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CD—pancreatic cancer	4.98e-06	0.000472	CbGpPWpGaD
Prednisone—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	4.97e-06	0.000472	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—pancreatic cancer	4.9e-06	0.000465	CbGpPWpGaD
Prednisone—ALB—Metabolism—CD44—pancreatic cancer	4.86e-06	0.000461	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.76e-06	0.000452	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.72e-06	0.000448	CbGpPWpGaD
Prednisone—ALB—Metabolism—GCG—pancreatic cancer	4.66e-06	0.000442	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMP—pancreatic cancer	4.5e-06	0.000427	CbGpPWpGaD
Prednisone—ALB—Metabolism—STK11—pancreatic cancer	4.38e-06	0.000416	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—CD44—pancreatic cancer	4.36e-06	0.000414	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CB—pancreatic cancer	4.34e-06	0.000412	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTGS2—pancreatic cancer	4.3e-06	0.000408	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—pancreatic cancer	4.27e-06	0.000406	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—CD44—pancreatic cancer	4.26e-06	0.000404	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—pancreatic cancer	4.23e-06	0.000402	CbGpPWpGaD
Prednisone—ALB—Hemostasis—SRC—pancreatic cancer	4.19e-06	0.000398	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—GCG—pancreatic cancer	4.18e-06	0.000397	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	4.11e-06	0.00039	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—GCG—pancreatic cancer	4.08e-06	0.000388	CbGpPWpGaD
Prednisone—ALB—Hemostasis—VEGFA—pancreatic cancer	4.08e-06	0.000387	CbGpPWpGaD
Prednisone—ALB—Hemostasis—NRAS—pancreatic cancer	4.03e-06	0.000383	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—STK11—pancreatic cancer	3.93e-06	0.000373	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—STK11—pancreatic cancer	3.84e-06	0.000364	CbGpPWpGaD
Prednisone—ALB—Metabolism—TYMS—pancreatic cancer	3.77e-06	0.000358	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PTEN—pancreatic cancer	3.75e-06	0.000356	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TGFB1—pancreatic cancer	3.74e-06	0.000356	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—pancreatic cancer	3.69e-06	0.00035	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GLP1R—pancreatic cancer	3.63e-06	0.000345	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—DPYD—pancreatic cancer	3.57e-06	0.000339	CbGpPWpGaD
Prednisone—ALB—Hemostasis—KRAS—pancreatic cancer	3.47e-06	0.000329	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	3.39e-06	0.000322	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—TYMS—pancreatic cancer	3.38e-06	0.000321	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—TYMS—pancreatic cancer	3.3e-06	0.000313	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—MYC—pancreatic cancer	3.19e-06	0.000303	CbGpPWpGaD
Prednisone—ALB—Hemostasis—PIK3CA—pancreatic cancer	3.19e-06	0.000303	CbGpPWpGaD
Prednisone—ALB—Hemostasis—TP53—pancreatic cancer	3.08e-06	0.000293	CbGpPWpGaD
Prednisone—ALB—Metabolism—APOE—pancreatic cancer	3.06e-06	0.000291	CbGpPWpGaD
Prednisone—ALB—Hemostasis—HRAS—pancreatic cancer	2.95e-06	0.00028	CbGpPWpGaD
Prednisone—ALB—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.9e-06	0.000275	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CG—pancreatic cancer	2.77e-06	0.000263	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—APOE—pancreatic cancer	2.75e-06	0.000261	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—APOE—pancreatic cancer	2.69e-06	0.000255	CbGpPWpGaD
Prednisone—ALB—Metabolism—PPARG—pancreatic cancer	2.67e-06	0.000253	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—PIK3CA—pancreatic cancer	2.64e-06	0.000251	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—CD44—pancreatic cancer	2.62e-06	0.000249	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—pancreatic cancer	2.6e-06	0.000247	CbGpPWpGaD
Prednisone—ALB—Hemostasis—AKT1—pancreatic cancer	2.6e-06	0.000247	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—GCG—pancreatic cancer	2.52e-06	0.000239	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CG—pancreatic cancer	2.48e-06	0.000236	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CD—pancreatic cancer	2.43e-06	0.000231	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CG—pancreatic cancer	2.42e-06	0.00023	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PPARG—pancreatic cancer	2.4e-06	0.000228	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—STK11—pancreatic cancer	2.36e-06	0.000225	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PPARG—pancreatic cancer	2.34e-06	0.000222	CbGpPWpGaD
Prednisone—NR3C1—Gene Expression—AKT1—pancreatic cancer	2.21e-06	0.00021	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CD—pancreatic cancer	2.18e-06	0.000207	CbGpPWpGaD
Prednisone—SLCO1A2—Metabolism—AKT1—pancreatic cancer	2.16e-06	0.000205	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CD—pancreatic cancer	2.13e-06	0.000202	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CB—pancreatic cancer	2.12e-06	0.000201	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTGS2—pancreatic cancer	2.1e-06	0.000199	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.03e-06	0.000193	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CB—pancreatic cancer	1.9e-06	0.000181	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTGS2—pancreatic cancer	1.89e-06	0.000179	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CB—pancreatic cancer	1.86e-06	0.000176	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTGS2—pancreatic cancer	1.84e-06	0.000175	CbGpPWpGaD
Prednisone—ALB—Metabolism—PTEN—pancreatic cancer	1.83e-06	0.000174	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—APOE—pancreatic cancer	1.65e-06	0.000157	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PTEN—pancreatic cancer	1.64e-06	0.000156	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PTEN—pancreatic cancer	1.6e-06	0.000152	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.49e-06	0.000142	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.44e-06	0.000137	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.31e-06	0.000125	CbGpPWpGaD
Prednisone—ALB—Metabolism—PIK3CA—pancreatic cancer	1.29e-06	0.000123	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—PIK3CA—pancreatic cancer	1.16e-06	0.00011	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.14e-06	0.000109	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.13e-06	0.000108	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—PIK3CA—pancreatic cancer	1.13e-06	0.000107	CbGpPWpGaD
Prednisone—ALB—Metabolism—AKT1—pancreatic cancer	1.06e-06	0.0001	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PTEN—pancreatic cancer	9.89e-07	9.39e-05	CbGpPWpGaD
Prednisone—CYP2C19—Metabolism—AKT1—pancreatic cancer	9.47e-07	9e-05	CbGpPWpGaD
Prednisone—ABCB1—Metabolism—AKT1—pancreatic cancer	9.25e-07	8.78e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	6.97e-07	6.62e-05	CbGpPWpGaD
Prednisone—CYP3A4—Metabolism—AKT1—pancreatic cancer	5.7e-07	5.41e-05	CbGpPWpGaD
